SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 37 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,800,000 | -55.8% | 473,562 | -47.6% | 0.39% | -73.2% |
| Q4 2021 | $4,069,000 | -3.4% | 904,225 | 0.0% | 1.46% | +18.3% |
| Q3 2021 | $4,214,000 | -33.9% | 904,225 | 0.0% | 1.23% | -29.7% |
| Q2 2021 | $6,375,000 | +24.1% | 904,225 | 0.0% | 1.75% | +45.2% |
| Q1 2021 | $5,136,000 | +457.0% | 904,225 | +352.1% | 1.21% | +488.8% |
| Q4 2020 | $922,000 | +18.5% | 200,000 | 0.0% | 0.20% | -8.9% |
| Q3 2020 | $778,000 | -92.0% | 200,000 | -41.2% | 0.22% | -91.3% |
| Q2 2020 | $9,778,000 | +295.1% | 340,000 | +195.7% | 2.58% | +293.3% |
| Q1 2020 | $2,475,000 | – | 115,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,431,705 | $14,371,000 | 5.72% |
| Ghost Tree Capital, LLC | 904,225 | $5,136,000 | 1.21% |
| RA Capital Management | 5,914,252 | $34,953,000 | 0.53% |
| NEA Management Company, LLC | 2,997,682 | $17,716,000 | 0.40% |
| Vivo Capital, LLC | 1,232,394 | $7,283,000 | 0.26% |
| Monashee Investment Management LLC | 176,057 | $1,040,000 | 0.16% |
| Ikarian Capital, LLC | 676,294 | $3,997,000 | 0.14% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $11,146,000 | 0.13% |
| SAMLYN CAPITAL, LLC | 1,232,394 | $7,283,000 | 0.10% |
| Maven Securities LTD | 173,029 | $1,026,000 | 0.05% |